TRxADE HEALTH MEDS Stock
TRxADE HEALTH Price Chart
TRxADE HEALTH MEDS Financial and Trading Overview
| TRxADE HEALTH stock price | 7.31 USD |
| Previous Close | 0.3 USD |
| Open | 0.3 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 900 |
| Day's Range | 0.3 - 0.35 USD |
| 52 Week Range | 0.25 - 1.79 USD |
| Volume | 225.33K USD |
| Avg. Volume | 433.83K USD |
| Market Cap | 3.36M USD |
| Beta (5Y Monthly) | 1.285211 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.46 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.9 USD |
MEDS Valuation Measures
| Enterprise Value | 3.01M USD |
| Trailing P/E | N/A |
| Forward P/E | 16.445002 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.3211981 |
| Price/Book (mrq) | 5.1390624 |
| Enterprise Value/Revenue | 0.288 |
| Enterprise Value/EBITDA | -1.003 |
Trading Information
TRxADE HEALTH Stock Price History
| Beta (5Y Monthly) | 1.285211 |
| 52-Week Change | -77.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.79 USD |
| 52 Week Low | 0.25 USD |
| 50-Day Moving Average | 0.32 USD |
| 200-Day Moving Average | 0.56 USD |
MEDS Share Statistics
| Avg. Volume (3 month) | 433.83K USD |
| Avg. Daily Volume (10-Days) | 243.68K USD |
| Shares Outstanding | 10.21M |
| Float | 5.27M |
| Short Ratio | 1.33 |
| % Held by Insiders | 51.92% |
| % Held by Institutions | 8.57% |
| Shares Short | 92.88K |
| Short % of Float | 1.73% |
| Short % of Shares Outstanding | 0.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -30.50% |
| Operating Margin (ttm) | -28.79% |
| Gross Margin | 45.88% |
| EBITDA Margin | -28.66% |
Management Effectiveness
| Return on Assets (ttm) | -38.097% |
| Return on Equity (ttm) | -184.58% |
Income Statement
| Revenue (ttm) | 10.46M USD |
| Revenue Per Share (ttm) | 1.17 USD |
| Quarterly Revenue Growth (yoy) | -30.59% |
| Gross Profit (ttm) | 4.58M USD |
| EBITDA | -2997143 USD |
| Net Income Avi to Common (ttm) | -2837661 USD |
| Diluted EPS (ttm) | -0.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.19M USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 1.04M USD |
| Total Debt/Equity (mrq) | 158.22 USD |
| Current Ratio (mrq) | 0.936 |
| Book Value Per Share (mrq) | 0.064 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1456689 USD |
| Levered Free Cash Flow (ttm) | -505613 USD |
Profile of TRxADE HEALTH
| Country | United States |
| State | FL |
| City | Lutz |
| Address | 2420 Brunello Trace |
| ZIP | 33558 |
| Phone | 800 261 0281 |
| Website | https://www.trxadehealth.com |
| Industry | Pharmaceutical Retailers |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.
Q&A For TRxADE HEALTH Stock
What is a current MEDS stock price?
TRxADE HEALTH MEDS stock price today per share is 7.31 USD.
How to purchase TRxADE HEALTH stock?
You can buy MEDS shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TRxADE HEALTH?
The stock symbol or ticker of TRxADE HEALTH is MEDS.
Which industry does the TRxADE HEALTH company belong to?
The TRxADE HEALTH industry is Pharmaceutical Retailers.
How many shares does TRxADE HEALTH have in circulation?
The max supply of TRxADE HEALTH shares is 1.21M.
What is TRxADE HEALTH Price to Earnings Ratio (PE Ratio)?
TRxADE HEALTH PE Ratio is now.
What was TRxADE HEALTH earnings per share over the trailing 12 months (TTM)?
TRxADE HEALTH EPS is -5.46 USD over the trailing 12 months.
Which sector does the TRxADE HEALTH company belong to?
The TRxADE HEALTH sector is Healthcare.
TRxADE HEALTH MEDS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}